Clinical Challenges in the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Literature Review

od Nagaraj, Gayathri, Ma, Cynthia X.
Wydane w Adv Ther (2020)

Neoadjuvant Therapy in Operable Breast Cancer: Application to Triple Negative Breast Cancer

od Ademuyiwa, Foluso O., Ellis, Matthew J., Ma, Cynthia X.
Wydane 2013

The ALTERNATE trial: assessing a biomarker driven strategy for the treatment of post-menopausal women with ER+/Her2− invasive breast cancer

od Suman, Vera Jean, Ellis, Matthew J., Ma, Cynthia X.
Wydane w Chin Clin Oncol (2015)

PI3K inhibition enhances the anti-tumor effect of eribulin in triple negative breast cancer

od Rajput, Sandeep, Guo, Zhanfang, Li, Shunqiang, Ma, Cynthia X.
Wydane w Oncotarget (2019)

Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics

od Ma, Cynthia X., Janetka, James W., Piwnica-Worms, Helen
Wydane w Trends Mol Med (2010)

Differences in the mutational landscape of triple negative breast cancer in African Americans and Caucasians

od Ademuyiwa, Foluso O., Tao, Yu, Luo, Jingqin, Weilbaecher, Katherine, Ma, Cynthia X.
Wydane w Breast Cancer Res Treat (2016)

Racial differences in outcomes of triple-negative breast cancer

od Pacheco, Jose M., Gao, Feng, Bumb, Caroline, Ellis, Matthew J., Ma, Cynthia X.
Wydane w Breast Cancer Res Treat (2013)

Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer

od Rajput, Sandeep, Khera, Nimmish, Guo, Zhanfang, Hoog, Jeremy, Li, Shunqiang, Ma, Cynthia X.
Wydane w Oncotarget (2016)

Combined Targeting of mTOR and AKT is an Effective Strategy for Basal-like Breast Cancer in Patient-derived Xenograft Models

od Xu, Siguang, Li, Shunqiang, Guo, Zhanfang, Luo, Jingqin, Ellis, Matthew J., Ma, Cynthia X.
Wydane 2013

HER2 mutated breast cancer responds to treatment with single agent neratinib, a second generation HER2/EGFR tyrosine kinase inhibitor

od Ben–Baruch, Noa Efrat, Bose, Ron, Kavuri, Shyam M., Ma, Cynthia X., Ellis, Matthew J.
Wydane w J Natl Compr Canc Netw (2015)

Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy

od Dehdashti, Farrokh, Wu, Ningying, Ma, Cynthia X., Naughton, Michael J., Katzenellenbogen, John A., Siegel, Barry A.
Wydane w Nat Commun (2021)

United States Breast Cancer Mortality Trends in Young Women According to Race

od Ademuyiwa, Foluso O., Gao, Feng, Hao, Lin, Morgensztern, Daniel, Aft, Rebecca L., Ma, Cynthia X., Ellis, Matthew J.
Wydane w Cancer (2014)

Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Resp...

od Fisher, Carla S., Ma, Cynthia X., Gillanders, William E., Aft, Rebecca L., Eberlein, Timothy J., Gao, Feng, Margenthaler, Julie A.
Wydane 2011

The feasibility of using metacognitive-strategy training to improve cognitive performance and neural connectivity in women with chemotherapy-induced cognitive impairment

od Wolf, Timothy J., Doherty, Meghan, Kallogjeri, Dorina, Coalson, Rebecca S., Nicklaus, Joyce, Ma, Cynthia X., Schlaggar, Bradley L., Piccirillo, Jay
Wydane w Oncology (2016)

Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer

od Sanchez, Cesar G, Ma, Cynthia X, Crowder, Robert J, Guintoli, Therese, Phommaly, Chanpheng, Gao, Feng, Lin, Li, Ellis, Matthew J
Wydane 2011

Cognitive Impairment after Chemotherapy Related to Atypical Network Architecture for Executive Control

od Piccirillo, Jay F., Hardin, Frances Mei, Nicklaus, Joyce, Kallogjeri, Dorina, Wilson, Michael, Ma, Cynthia X., Coalson, Rebecca S., Shimony, Joshua, Schlaggar, Bradley L.
Wydane w Oncology (2015)

Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER(+) breast cancer

od Shee, Kevin, Jiang, Amanda, Varn, Frederick S., Liu, Stephanie, Traphagen, Nicole A., Owens, Philip, Ma, Cynthia X., Hoog, Jeremy, Cheng, Chao, Golub, Todd R., Straussman, Ravid, Miller, Todd W.
Wydane w FASEB J (2019)

Cisplatin +/− rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer

od Kalra, Maitri, Tong, Yan, Jones, David R., Walsh, Tom, Danso, Michael A., Ma, Cynthia X., Silverman, Paula, King, Mary-Claire, Badve, Sunil S., Perkins, Susan M., Miller, Kathy D.
Wydane w NPJ Breast Cancer (2021)

A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor Positive Metastatic Breast Cancer

od Ma, Cynthia X., Sanchez, Cesar, Gao, Feng, Crowder, Robert, Naughton, Michael, Pluard, Timothy, Creekmore, Allison, Guo, Zhanfang, Hoog, Jeremy, Lockhart, A. Craig, Doyle, Laurence, Erlichman, Charles, Ellis, Matthew J.
Wydane w Clin Cancer Res (2016)

Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: feasibility of an antibody-based companion diagnostic agent

od Marquez-Nostra, Bernadette V., Lee, Supum, Laforest, Richard, Vitale, Laura, Nie, Xingyu, Hyrc, Krzysztof, Keler, Tibor, Hawthorne, Thomas, Hoog, Jeremy, Li, Shunqiang, Dehdashti, Farrokh, Ma, Cynthia X., Lapi, Suzanne E.
Wydane w Oncotarget (2017)